Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R First

Showing results (241-250 of 266) with videos related to

Pageof 27
Sort By:
Transplantation|July 1, 1992
Use of indomethacin to minimize the adverse reactions associated with orthoclone OKT3 treatment of kidney allograft rejectionC F Shield, L Kahana, J Pirsch, et al.
Transplantation|January 1, 1992
A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipientsT J Schroeder, T Helling, R M McKenna, et al.
Transplantation Proceedings|March 20, 1999
Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from SandimmuneM R First, P Weiskittel, M L Burton, et al.
Transplantation|February 1, 1989
A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipientsT J Schroeder, M E Brunson, A J Pesce, et al.
Transplantation|February 1, 1992
The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trialJ W Alexander, G F Babcock, M R First, et al.
Transplantation Proceedings|April 26, 2005
Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimenR Alloway, S Steinberg, K Khalil, et al.
Transplantation|January 1, 1990
Antimurine antibody formation following OKT3 therapyT J Schroeder, M R First, M E Mansour, et al.
Transplantation Proceedings|April 26, 2005
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimenS Florman, R Alloway, M Kalayoglu, et al.
Transplantation Proceedings|February 1, 1989
Immune monitoring during retreatment with OKT3M R First, T J Schroeder, P E Hurtubise, et al.
Transplantation|January 1, 1989
Successful retreatment of allograft rejection with OKT3M R First, T J Schroeder, P E Hurtubise, et al.
Pageof 27

Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Transplantation|July 1, 1992
Use of indomethacin to minimize the adverse reactions associated with orthoclone OKT3 treatment of kidney allograft rejectionC F Shield, L Kahana, J Pirsch, et al.
Transplantation|January 1, 1992
A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipientsT J Schroeder, T Helling, R M McKenna, et al.
Transplantation Proceedings|March 20, 1999
Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from SandimmuneM R First, P Weiskittel, M L Burton, et al.
Transplantation|February 1, 1989
A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipientsT J Schroeder, M E Brunson, A J Pesce, et al.
Transplantation|February 1, 1992
The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trialJ W Alexander, G F Babcock, M R First, et al.
Transplantation Proceedings|April 26, 2005
Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimenR Alloway, S Steinberg, K Khalil, et al.
Transplantation|January 1, 1990
Antimurine antibody formation following OKT3 therapyT J Schroeder, M R First, M E Mansour, et al.
Transplantation Proceedings|April 26, 2005
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimenS Florman, R Alloway, M Kalayoglu, et al.
Transplantation Proceedings|February 1, 1989
Immune monitoring during retreatment with OKT3M R First, T J Schroeder, P E Hurtubise, et al.
Transplantation|January 1, 1989
Successful retreatment of allograft rejection with OKT3M R First, T J Schroeder, P E Hurtubise, et al.
Pageof 27